287
Views
31
CrossRef citations to date
0
Altmetric
Original Articles

Exogeneous Cytosine Deaminase Gene Expression in Bifidobacterium breve I-53-8w for Tumor-Targeting Enzyme/Prodrug Therapy

, , , &
Pages 2921-2926 | Received 10 May 2007, Accepted 08 Sep 2007, Published online: 22 May 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Fadoua Mouni, Eliane Aissi, Jesús Hernandez, Patricia Gorocica, Stéphane Bouquelet, Edgar Zenteno, Ricardo Lascurain & Yonathan Garfias. (2009) Effect of Bifidobacterium bifidum DSM 20082 Cytoplasmic Fraction on Human Immune Cells. Immunological Investigations 38:1, pages 104-115.
Read now

Articles from other publishers (30)

Leon M. T. Dicks & Wian Vermeulen. (2022) Do Bacteria Provide an Alternative to Cancer Treatment and What Role Does Lactic Acid Bacteria Play?. Microorganisms 10:9, pages 1733.
Crossref
Yulin Kang, Xiaohui Zhai, Sifen Lu, Ivan Vuletic, Lin Wang, Kun Zhou, Zhiqiang Peng, Qiushi Ren & Zhaoheng Xie. (2022) A Hybrid Imaging Platform(CT/PET/FMI) for Evaluating Tumor Necrosis and Apoptosis in Real-Time. Frontiers in Oncology 12.
Crossref
Saumya Darshana Patra, Aryashree Arunima & Mrutyunjay Suar. 2022. Microbial Engineering for Therapeutics. Microbial Engineering for Therapeutics 3 40 .
Shun’ichiro Taniguchi. (2021) In Situ Delivery and Production System (iDPS) of Anti-Cancer Molecules with Gene-Engineered Bifidobacterium. Journal of Personalized Medicine 11:6, pages 566.
Crossref
Sheetal Parida & Dipali Sharma. (2021) The Microbiome and Cancer: Creating Friendly Neighborhoods and Removing the Foes Within. Cancer Research 81:4, pages 790-800.
Crossref
Swapnil C. Kamble, Farhan F. Shaikh & Joyita Sarkar. 2021. Nanotechnology for Advances in Medical Microbiology. Nanotechnology for Advances in Medical Microbiology 331 347 .
Lorena Ruiz, Maria Esteban-Torres & Douwe van Sinderen. 2021. Bifidobacteria. Bifidobacteria 157 182 .
Fanglei Zuo, Shangwu Chen & Harold Marcotte. (2020) Engineer probiotic bifidobacteria for food and biomedical applications - Current status and future prospective. Biotechnology Advances 45, pages 107654.
Crossref
Noura S. Dosoky, Linda S. May-Zhang & Sean S. Davies. (2020) Engineering the gut microbiota to treat chronic diseases. Applied Microbiology and Biotechnology 104:18, pages 7657-7671.
Crossref
Nealie Ngo, Khalil Choucair, Justin F Creeden, Hanan Qaqish, Krupa Bhavsar, Chantal Murphy, Kendra Lian, Mary T Albrethsen, Laura Stanbery, Richard C Phinney, F Charles Brunicardi, Lance Dworkin & John Nemunaitis. (2019) Bifidobacterium spp : the promising Trojan Horse in the era of precision oncology . Future Oncology 15:33, pages 3861-3876.
Crossref
Hongyun Wei, Linlin Chen, Guanghui Lian, Junwen Yang, Fujun Li, Yiyou Zou, Fanggen Lu & Yani Yin. (2018) Antitumor mechanisms of bifidobacteria (Review). Oncology Letters.
Crossref
L Wang, I Vuletic, D Deng, W Crielaard, Z Xie, K Zhou, J Zhang, H Sun, Q Ren & C Guo. (2017) Bifidobacterium breve as a delivery vector of IL-24 gene therapy for head and neck squamous cell carcinoma in vivo. Gene Therapy 24:11, pages 699-705.
Crossref
Panos Lehouritis, Glenn Hogan & Mark Tangney. (2017) Designer bacteria as intratumoural enzyme biofactories. Advanced Drug Delivery Reviews 118, pages 8-23.
Crossref
Annika Osswald, Zhongke Sun, Verena Grimm, Grace Ampem, Karin Riegel, Astrid M. Westendorf, Wolfgang Sommergruber, Kerstin Otte, Peter Dürre & Christian U. Riedel. (2015) Three-dimensional tumor spheroids for in vitro analysis of bacteria as gene delivery vectors in tumor therapy. Microbial Cell Factories 14:1.
Crossref
Charles H. Jones, Anders P. Hakansson & Blaine A. Pfeifer. (2014) Biomaterials at the interface of nano- and micro-scale vector–cellular interactions in genetic vaccine design. J. Mater. Chem. B 2:46, pages 8053-8068.
Crossref
Panos Lehouritis, Caroline Springer & Mark Tangney. (2013) Bacterial-directed enzyme prodrug therapy. Journal of Controlled Release 170:1, pages 120-131.
Crossref
S. Guglielmetti, B. Mayo & P. Álvarez-Martín. (2013) Mobilome and genetic modification of bifidobacteria. Beneficial Microbes 4:2, pages 143-166.
Crossref
Stefano Tacconi, Barbara Sgorbati, Monica Modesto, Bruno Biavati, Lorenzo Nissen & Paola Mattarelli. (2012) Carbohydrate stress-related response in Bifidobacterium pseudolongum subsp. globosum. Annals of Microbiology 62:4, pages 1751-1756.
Crossref
M Cronin, R M Stanton, K P Francis & M Tangney. (2012) Bacterial vectors for imaging and cancer gene therapy: a review. Cancer Gene Therapy 19:11, pages 731-740.
Crossref
Zhongke Sun, Annika Baur, Daria Zhurina, Jing Yuan & Christian U. Riedel. (2012) Accessing the Inaccessible: Molecular Tools for Bifidobacteria. Applied and Environmental Microbiology 78:15, pages 5035-5042.
Crossref
Jianlong He, Kouta Sakaguchi & Tohru Suzuki. (2012) Determination of the ribosome-binding sequence and spacer length between binding site and initiation codon for efficient protein expression in Bifidobacterium longum 105-A. Journal of Bioscience and Bioengineering 113:4, pages 442-444.
Crossref
Satoru FUKIYA, Yosuke HIRAYAMA, Mikiyasu SAKANAKA, Yasunobu KANO & Atsushi YOKOTA. (2012) Technological Advances in Bifidobacterial Molecular Genetics: Application to Functional Genomics and Medical Treatments. Bioscience of Microbiota, Food and Health 31:2, pages 15-25.
Crossref
Michelle Cronin, Marco Ventura, Gerald F. Fitzgerald & Douwe van Sinderen. (2011) Progress in genomics, metabolism and biotechnology of bifidobacteria. International Journal of Food Microbiology 149:1, pages 4-18.
Crossref
Ju-Hoon Lee & Daniel J. O'Sullivan. (2010) Genomic Insights into Bifidobacteria. Microbiology and Molecular Biology Reviews 74:3, pages 378-416.
Crossref
Sara Leschner & Siegfried Weiss. (2010) Salmonella—allies in the fight against cancer. Journal of Molecular Medicine 88:8, pages 763-773.
Crossref
Siyu Cao, Allan Cripps & Ming Q Wei. (2009) New strategies for cancer gene therapy: Progress and opportunities. Clinical and Experimental Pharmacology and Physiology 37:1, pages 108-114.
Crossref
Wei Tang, Yunfeng He, Shengcai Zhou, Yongping Ma & Geli Liu. (2009) A novel Bifidobacterium infantis-mediated TK/GCV suicide gene therapy system exhibits antitumor activity in a rat model of bladder cancer. Journal of Experimental & Clinical Cancer Research 28:1.
Crossref
Zheng-Jun Yi, Yu-Rong Fu, Meng Li, Kun-Shan Gao & Xu-Guang Zhang. (2009) Effect of LTA isolated from bifidobacteria on d-galactose-induced aging. Experimental Gerontology 44:12, pages 760-765.
Crossref
Fabrizio Arigoni & Harald Brüssow. (2009) Food and gut microbes for thoughts. Microbial Biotechnology 2:2, pages 129-130.
Crossref
Koji Nomoto, Mayumi Kiwaki & Hirokazu Tsuji. 2008. Handbook of Probiotics and Prebiotics. Handbook of Probiotics and Prebiotics 189 255 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.